Compare VLRS & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VLRS | CRMD |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 958.1M |
| IPO Year | N/A | 2010 |
| Metric | VLRS | CRMD |
|---|---|---|
| Price | $9.18 | $11.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $9.40 | ★ $17.43 |
| AVG Volume (30 Days) | 524.2K | ★ 2.7M |
| Earning Date | 02-23-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.25 |
| Revenue | ★ $2,990,662,000.00 | $214,303,672.00 |
| Revenue This Year | N/A | $627.89 |
| Revenue Next Year | $11.07 | $40.95 |
| P/E Ratio | ★ N/A | $5.41 |
| Revenue Growth | N/A | ★ 1647.67 |
| 52 Week Low | $3.49 | $5.60 |
| 52 Week High | $9.99 | $17.43 |
| Indicator | VLRS | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 67.44 | 46.23 |
| Support Level | $8.76 | $11.62 |
| Resistance Level | $9.46 | $13.02 |
| Average True Range (ATR) | 0.36 | 0.54 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 66.30 | 3.83 |
Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.